Indian Institute of Technology Kanpur (IITK) has transferred its non-invasive oral cancer detection technology, Munh Parikshak, to Scangenie Scientific, to aid in widespread adoption.

A formal technology licensing agreement has been signed between IITK and Scangenie Scientific, marking the beginning of a strategic partnership.

Invented by the chemical engineering department, led by professor Jayant Kumar Singh, this portable device aims to revolutionise early cancer detection by providing quick and accurate results.

The device uses special lights and a camera to inspect the oral cavity, instantly classifying images as normal, pre-cancerous, or cancerous.

The results can be viewed on a smartphone app and are securely stored on cloud servers, enabling easy self-testing and continuous monitoring.

Munh Parikshak is a user-friendly device that connects wirelessly to various smart devices and has a built-in power backup. It records health history for ongoing assessment and delivers immediate oral health reports.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The device has a 90% accuracy rate in clinical settings and offers a quick, painless screening process.

It is safe, free from radiation, and does not need additional chemicals or procedures, making it an ideal solution for widespread use in early cancer detection.

IITK research and development dean Tarun Gupta said: “The signing of the MOU with Scangenie Scientific marks a significant milestone in our mission to transition research and development into commercially viable products.

“The institute’s licensing rate has also seen an increase, which motivates us to further support research across various fields. This MOU aims to effectively market our invention within the healthcare sector, ultimately affordable and beneficial to everyone.”

This collaboration between IITK and Scangenie Scientific represents a significant step towards improving healthcare outcomes through innovative technology.